Lot numbers can be found on the outside label of a product:
Please log in for operation!
*For research and further manufacturing use only, not for direct human use.
Structure of 1421372-66-8
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
Mutated EGFR-IN-1 is a potent, selective inhibitor targeting oncogenic mutant forms of epidermal growth factor receptor (EGFR), including T790M and L858R variants. This compound exhibits enhanced binding affinity to mutated kinase domains while maintaining minimal activity against wild-type EGFR, enabling precise suppression of aberrant signaling pathways in resistant non-small cell lung cancer models.
Mutated EGFR-IN-1 serves as a selective inhibitor targeting oncogenic mutant forms of the epidermal growth factor receptor, particularly L858R and exon 19 deletion variants. It functions as a potent, ATP-competitive kinase inhibitor with demonstrated utility in preclinical models of non-small cell lung cancer. The compound exhibits favorable stability and solubility profiles, enabling reliable use in cellular assays and biochemical screening workflows.
|
GHS Pictogram :
|
GHS No : GHS07
|
|
Signal Word : Warning
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H302-H315-H319-H335
|
|
|
Precautionary Statements : P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Lot numbers can be found on the outside label of a product: